Yoshifumi Suga

961 citations
16 papers · 412 indexed · h-index 8
Topics
Hepatocellular Carcinoma Treatment and Prognosis (6 papers)Liver Disease Diagnosis and Treatment (5 papers)Dysphagia Assessment and Management (4 papers)
Partner nations
JapanUnited States

In The Last Decade

Yoshifumi Suga

14 papers receiving 409 citations

Peers

Yoshifumi Suga
Comparison fields: 5 of 51
  • Hepatology 255
  • Epidemiology 229
  • Physiology 149
  • Surgery 64
  • Oncology 63
Replace Toshihiko Aibiki with:
Toshihiko Aibiki Japan
Tomonari Okudaira Japan
Tomoe Kawamura Japan
Hidetaro Ueki Japan
Hideomi Tomida Japan
Soichi Iritani Japan
Shirin Feshtali Netherlands
Akiko Toshimori Japan
Shunji Koya Japan
Ayumu Goto Japan
Yoshifumi Suga relative to Toshihiko Aibiki Japan Toshihiko Aibiki's profile →
Citations per field
00.5×1.5×
Toshihiko Aibiki · 1×
Citations per year

Countries citing papers authored by Yoshifumi Suga

Since Specialization
Citations

This map shows the geographic impact of Yoshifumi Suga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshifumi Suga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshifumi Suga more than expected).

Fields of papers citing papers by Yoshifumi Suga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshifumi Suga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshifumi Suga. The network helps show where Yoshifumi Suga may publish in the future.

Co-authorship network of co-authors of Yoshifumi Suga

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshifumi Suga. A scholar is included among the top collaborators of Yoshifumi Suga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshifumi Suga. Yoshifumi Suga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 2
2 5
3 4
4 14
5 1
6 22
7 0
8 2
9 49
10 0
11 81
12 33
13 14
14 158
15 1
16 26

About Yoshifumi Suga

Yoshifumi Suga is a scholar working on Hepatology, Speech and Hearing and Anesthesiology and Pain Medicine, having authored 16 papers that have together received 412 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Dysphagia Assessment and Management (4 papers). The work is most often cited by research in Hepatology (255 citations), Epidemiology (229 citations) and Physiology (149 citations). Yoshifumi Suga has collaborated with scholars based in Japan and United States. Frequent co-authors include Tomoyuki Ninomiya, Tomonari Okudaira, Atsushi Hiraoka, Toshihiko Aibiki, Kojiro Michitaka, Hideki Miyata, Nobuaki Azemoto, Tomoe Kawamura, Hiroka Yamago and Masashi Hirooka. Their work appears in journals such as Journal of Gastroenterology and Hepatology, Journal of Gastroenterology and European Journal of Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026